UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Frontiers in physiology, 2020-10, Vol.11, p.583333-583333

2020

Volltextzugriff (PDF)

Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis

JCI insight, 2021-12, Vol.6 (24)

2021

Volltextzugriff (PDF)

Pre-Operative Localization of Axillary Lymph Nodes with Tattoo Ink: A Preliminary Report

Archives of breast cancer, 2021-05, p.143-148

2021

Volltextzugriff (PDF)

Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder

The American journal of surgical pathology, 2017-11, Vol.41 (11), p.1570-1575

2017

Volltextzugriff (PDF)

Peripheral Nerve Sheath Tumors

Surgical pathology clinics, 2011-09, Vol.4 (3), p.761-782

Cimino-Mathews, Ashley M., MD

2011

Volltextzugriff (PDF)

Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules

Immunologic research, 2004-01, Vol.29 (1-3), p.231-240

2004

Volltextzugriff (PDF)

The role of GATA3 in breast carcinomas: a review

Human pathology, 2016-02, Vol.48, p.37-47

2016

Volltextzugriff (PDF)

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Human pathology, 2016-01, Vol.47 (1), p.52-63

2016

Volltextzugriff (PDF)

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Human pathology, 2013-07, Vol.44 (7), p.1341-1349

2013

Volltextzugriff (PDF)

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

Human pathology, 2013-06, Vol.44 (6), p.959-965

2013

Volltextzugriff (PDF)

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study

Human pathology, 2013-10, Vol.44 (10), p.2055-2063

2013

Volltextzugriff (PDF)

Breast calcifications on mammography from systemic amyloidosis: A case report

Radiology case reports, 2024-09, Vol.19 (9), p.3740-3747

2024

Volltextzugriff (PDF)

Induction of anti-tumor immunity by a protein transfer mediated cancer vaccine (41.49)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.41-41.49

2009

Volltextzugriff (PDF)

Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy

Human pathology, 2012-07, Vol.43 (7), p.1003-1011

2012

Volltextzugriff (PDF)

A Subset of Fat-Predominant Angiomyolipomas Label for MDM2: A Potential Diagnostic Pitfall

Human pathology, 2016-11, Vol.57, p.7-12

2016

Volltextzugriff (PDF)

Utility of uroplakin II expression as a marker of urothelial carcinoma

Human pathology, 2015-01, Vol.46 (1), p.58-64

2015

Volltextzugriff (PDF)

Metastatic Disease to the Breast From Extramammary Malignancies: A Multimodality Pictorial Review

Current problems in diagnostic radiology, 2016-05, Vol.45 (3), p.225-232

2016

Volltextzugriff (PDF)

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway

Human pathology, 2013-11, Vol.44 (11), p.2494-2500

2013

Volltextzugriff (PDF)

Telomere length alterations unique to invasive lobular carcinoma

Human pathology, 2015-08, Vol.46 (8), p.1197-1203

2015

Volltextzugriff (PDF)

Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype

Human pathology, 2013-11, Vol.44 (11), p.2487-2493

2013

Volltextzugriff (PDF)

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

Human pathology, 2014-04, Vol.45 (4), p.880-883

2014

Volltextzugriff (PDF)

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical cancer research, 2020-08, Vol.26 (16), p.4268-4279

2020

Volltextzugriff (PDF)

Implications of the tumor immune microenvironment for staging and therapeutics

Modern pathology, 2018-02, Vol.31 (2), p.214-234

2018

Volltextzugriff (PDF)

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

Clinical cancer research, 2020-02, Vol.26 (3), p.545-551

2020

Volltextzugriff (PDF)

The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

The Journal of pathology, 2020-04, Vol.250 (5), p.667-684

2020

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(88)

Sprache

Englisch
(88)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer

Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis

Pre-Operative Localization of Axillary Lymph Nodes with Tattoo Ink: A Preliminary Report

Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder

Peripheral Nerve Sheath Tumors

Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules

The role of GATA3 in breast carcinomas: a review

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study

Breast calcifications on mammography from systemic amyloidosis: A case report

Induction of anti-tumor immunity by a protein transfer mediated cancer vaccine (41.49)

Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy

A Subset of Fat-Predominant Angiomyolipomas Label for MDM2: A Potential Diagnostic Pitfall

Utility of uroplakin II expression as a marker of urothelial carcinoma

Metastatic Disease to the Breast From Extramammary Malignancies: A Multimodality Pictorial Review

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway

Telomere length alterations unique to invasive lobular carcinoma

Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Implications of the tumor immune microenvironment for staging and therapeutics

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

Suchergebnisse filtern